CIK 0001708527 · Non-accelerated filer<br>Smaller reporting company
ELUTIA INC.
Sign in to watch- Ticker
- ELUT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474790334
- Phone
- 240-247-1143
- Business address
- 12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING, MD, 20904
- Former names
- AZIYO BIOLOGICS, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Option exercise | +15,390 | 21,997 | ||
| 2022-09-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −4,728 | $7.30 | $35K | 17,269 |
| 2022-09-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Stock Units | −15,390 | 0 | ||
| 2022-09-08 | Riebman Jerome CHIEF MEDICAL OFFICER | Option exercise | +14,758 | 20,093 | ||
| 2022-09-08 | Riebman Jerome CHIEF MEDICAL OFFICER | Shares withheld for taxes | −5,104 | $7.30 | $37K | 14,989 |
| 2022-09-08 | Riebman Jerome CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −14,758 | 0 | ||
| 2022-06-21 | Mills C Randal Interim President and CEO | Grant or award · Stock Option (Right to Buy) | +273,767 | 273,767 | ||
| 2022-06-21 | Mills C Randal Interim President and CEO | Grant or award · Stock Option (Right to Buy) | +182,511 | 182,511 | ||
| 2022-06-07 | Mills C Randal Director | Grant or award · Stock Option (Right to Buy) | +22,090 | 22,090 | ||
| 2022-06-07 | Makes Brigid Director | Grant or award · Stock Option (Right to Buy) | +22,090 | 22,090 | ||
| 2022-06-07 | Jordan Maybelle Director | Grant or award · Stock Option (Right to Buy) | +22,090 | 22,090 | ||
| 2022-06-07 | HighCape Capital, L.P. Director | Grant or award · Stock Option (Right to Buy) | +22,090 | 22,090 | ||
| 2022-06-07 | HighCape Capital, L.P. Director | Grant or award · Stock Option (Right to Buy) | +22,090 | 22,090 | ||
| 2022-05-11 | Birchview Capital, LP 10% owner | Purchase | +200 | $5.96 | $1K | 1,418,123 |
| 2022-03-10 | Englese Thomas CHIEF COMMERCIAL OFFICER | Sale | −276 | 6,607 | ||
| 2022-03-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Option exercise | +938 | 6,883 | ||
| 2022-03-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +31,000 | 31,000 | ||
| 2022-03-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Grant or award · Restricted Stock Units | +8,700 | 8,700 | ||
| 2022-03-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Stock Units | −938 | 2,812 | ||
| 2022-03-08 | Englese Thomas CHIEF COMMERCIAL OFFICER | Grant or award · Restricted Stock Units | +15,390 | 15,390 |
Page 13 of 17 · 330 trades